Cargando…
Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696706/ https://www.ncbi.nlm.nih.gov/pubmed/26691898 http://dx.doi.org/10.3201/eid2201.151272 |
_version_ | 1782407819223367680 |
---|---|
author | Kantele, Anu Mero, Sointu Kirveskari, Juha Lääveri, Tinja |
author_facet | Kantele, Anu Mero, Sointu Kirveskari, Juha Lääveri, Tinja |
author_sort | Kantele, Anu |
collection | PubMed |
description | Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%. |
format | Online Article Text |
id | pubmed-4696706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-46967062016-01-05 Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea Kantele, Anu Mero, Sointu Kirveskari, Juha Lääveri, Tinja Emerg Infect Dis Dispatch Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%. Centers for Disease Control and Prevention 2016-01 /pmc/articles/PMC4696706/ /pubmed/26691898 http://dx.doi.org/10.3201/eid2201.151272 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Dispatch Kantele, Anu Mero, Sointu Kirveskari, Juha Lääveri, Tinja Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea |
title | Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea |
title_full | Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea |
title_fullStr | Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea |
title_full_unstemmed | Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea |
title_short | Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea |
title_sort | increased risk for esbl-producing bacteria from co-administration of loperamide and antimicrobial drugs for travelers’ diarrhea |
topic | Dispatch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696706/ https://www.ncbi.nlm.nih.gov/pubmed/26691898 http://dx.doi.org/10.3201/eid2201.151272 |
work_keys_str_mv | AT kanteleanu increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea AT merosointu increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea AT kirveskarijuha increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea AT laaveritinja increasedriskforesblproducingbacteriafromcoadministrationofloperamideandantimicrobialdrugsfortravelersdiarrhea |